Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSNA to release three new journals in 2019

Come 2019, RSNA will begin publishing three new subspecialty online journals, according to a recent press release. 

October 23, 2017

Revised 2017 MRI guidelines for MS released

In January 2017, groups of neurologists, radiologists, and imaging scientists from North America and Europe met in Newark, New Jersey, to revise and update brain and spinal cord MRI guidelines to diagnosis and monitor multiple sclerosis (MS). On October 11, the official 2017 MRI guidelines were officially released on The Consortium of Multiple Sclerosis Centers (CMSC) website.

October 20, 2017

How an MRI could help predict neurological outcomes of cardiac arrest patients

According to an article from Cardiovascular Business, a new study published by Radiology shows that an MRI could help predict the long-term neurological outcomes of cardiac arrest survivors.

October 19, 2017

FUJIFILM debuts new video endoscopy system ELUXEO

From Oct. 13-18, FUJIFILM will be debuting its new innovative video endoscopy system ELUXEO™at the at the Annual Scientific Meeting of the World Congress of Gastroenterology (WCOG) at the American College of Gastroenterology (ACG) hosted at the Orange County Convention Center in Orlando, FL.

October 17, 2017

Brain, spinal cord MR imaging helps ID MS risk in children

New research from Yale University’s School of Medicine shows scans of the brain and spinal cord can be key to identifying changes in brain activity that can lead to multiple sclerosis (MS) in children.

October 17, 2017

Philips receives U.S. FDA 510(k) clearance to market its solution for 'small parts' ultrasound imaging

AMSTERDAM and TAIPEI, Taiwan -- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the new eL18-4 transducer with full solution for 'small parts' assessment, which is an ultrasound exam to detect abnormalities in the small organs that are close to the skin.

October 13, 2017

MRI Interventions announces Joseph Burnett as new president, CEO

Joseph Burnett announced as new President and CEO of MRI Interventions, Inc., effective November 7. 

October 12, 2017

SONOSCANNER obtains FDA approval to market ultraportable ultrasound scanner, U-lite EXP, in the U.S.

Ivry-sur-Seine - SONOSCANNER, a French company specializing in ultrasound systems, today announced that it received the Food and Drug Administration's approval (FDA) to market its new multi-purpose device, the U-lite EXP, in the United States, starting in October 2017.

October 5, 2017

Around the web

The newly approved AI models are designed to improve the detection of pulmonary embolisms and strokes in patients who undergo CT scans.

"I see, at least for the next decade, this being a SPECT and PET world, not one or the other," explained Tim Bateman, MD.

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab. 

Trimed Popup
Trimed Popup